跳至主要内容
临床试验/NCT01903668
NCT01903668撤回不适用

Determination of the Nature of the Endogenous Ligand of TREM-1 and Its Use as a New Diagnostic Biomarker in Sepsis

Centre Hospitalier Universitaire Dijon0 个研究点开始时间: 2012年4月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
plasma concentrations of sTREM-1

研究概览

简要总结

Step 1: Identification and characterisation of the TREM1L protein from samples already available characterised at the hospital Central of Nancy Step 2: Study of the isoforms of TREM1L in correlation with the prognosis of sepsis, Step 3: implementation of assay methods for TREM1L (ELISA or SUPRA MS) Step 4: Validation of assays for TREM1L and its isoforms in a larger number of subjects (inclusion of samples from Dijon CHU and Besançon CHU)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients hospitalised in a Medical Intensive Care unit whatever the reason
  • written informed consent obtained

排除标准

  • patients less than 18 years old or under guardianship, persons without national health insurance.

结局指标

主要结局

plasma concentrations of sTREM-1

时间窗: baseline

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验